In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
DNA Ginkgo Bioworks Holdings, Inc.
Harvard's free programming classes teach you how to think, debug, and adapt in an AI-driven world where knowing code matters more than ever.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback